Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review.
Saved in:
| Title: | Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review. |
|---|---|
| Authors: | Boyle, Jessica (AUTHOR), Vukicevic, Meri (AUTHOR), Koklanis, Konstandina (AUTHOR), Itsiopoulos, Catherine (AUTHOR) |
| Source: | Psychology, Health & Medicine. Apr2015, Vol. 20 Issue 3, p296-310. 15p. 1 Diagram, 1 Chart. |
| Subjects: | Vascular endothelial growth factor antagonists, Anesthesia, Anxiety, Fear, Medical information storage & retrieval systems, Psychology information storage & retrieval systems, Injections, MEDLINE, Online information services, Pain, Patient satisfaction, Research funding, Retinal degeneration, Systematic reviews, Triamcinolone, Visual analog scale, Bevacizumab, Patients' attitudes, Therapeutics |
| Geographic Terms: | Australia |
| Abstract: | Current therapy to slow disease progression in patients with neovascular age-related macular degeneration (AMD) often entails intra-vitreal injection of an anti-vascular endothelial growth factor (VEGF) agent, that begins with a three-month loading phase of four weekly injections followed by regular monthly visits with clinician-determined re-treatment. The effects of AMD on quality of life and visual function have been extensively reported in the literature, however, less is known about the burden imposed on patients by the arduous and often indefinite treatment schedule which habitually follows a diagnosis of wet AMD. To date, no systematic review has been conducted of research investigating patients’ experiences of anti-VEGF treatment for AMD. A systematic search of the Embase, Medline, PsycINFO and PubMed electronic databases was undertaken to identify all studies between January 2004 and December 2013, published in the English language and involving human participants. A hand-search of an additional four journals was conducted. Ten articles were identified for inclusion in this review. A critical appraisal was undertaken using the Critical Appraisal Skills Programme Qualitative Research Checklist and the results synthesised to form a narrative review. Few studies to date have investigated patients’ experiences of treatment for AMD. These studies have focused primarily on patients’ experiences of the injection procedure with respect to pain and anxiety. Anticipated discomfort is often greater than actual discomfort experienced during intra-vitreal injection. However, different stages of the treatment procedure produce varying levels of patient discomfort. No one method of anaesthesia has consistently been shown to be more effective in reducing discomfort associated with treatment. Common reasons underlying patient apprehension surrounding treatment include the thought of having an injection, fear of losing eyesight and fear of the unknown. Whilst these studies have not been without their methodological limitations, they provide a platform for further exploration of the patient experience. [ABSTRACT FROM PUBLISHER] |
| Copyright of Psychology, Health & Medicine is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 100808470 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Boyle%2C+Jessica%22">Boyle, Jessica</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vukicevic%2C+Meri%22">Vukicevic, Meri</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Koklanis%2C+Konstandina%22">Koklanis, Konstandina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Itsiopoulos%2C+Catherine%22">Itsiopoulos, Catherine</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Psychology%2C+Health+%26+Medicine%22">Psychology, Health & Medicine</searchLink>. Apr2015, Vol. 20 Issue 3, p296-310. 15p. 1 Diagram, 1 Chart. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Vascular+endothelial+growth+factor+antagonists%22">Vascular endothelial growth factor antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Anesthesia%22">Anesthesia</searchLink><br /><searchLink fieldCode="DE" term="%22Anxiety%22">Anxiety</searchLink><br /><searchLink fieldCode="DE" term="%22Fear%22">Fear</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+information+storage+%26+retrieval+systems%22">Medical information storage & retrieval systems</searchLink><br /><searchLink fieldCode="DE" term="%22Psychology+information+storage+%26+retrieval+systems%22">Psychology information storage & retrieval systems</searchLink><br /><searchLink fieldCode="DE" term="%22Injections%22">Injections</searchLink><br /><searchLink fieldCode="DE" term="%22MEDLINE%22">MEDLINE</searchLink><br /><searchLink fieldCode="DE" term="%22Online+information+services%22">Online information services</searchLink><br /><searchLink fieldCode="DE" term="%22Pain%22">Pain</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+satisfaction%22">Patient satisfaction</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Retinal+degeneration%22">Retinal degeneration</searchLink><br /><searchLink fieldCode="DE" term="%22Systematic+reviews%22">Systematic reviews</searchLink><br /><searchLink fieldCode="DE" term="%22Triamcinolone%22">Triamcinolone</searchLink><br /><searchLink fieldCode="DE" term="%22Visual+analog+scale%22">Visual analog scale</searchLink><br /><searchLink fieldCode="DE" term="%22Bevacizumab%22">Bevacizumab</searchLink><br /><searchLink fieldCode="DE" term="%22Patients'+attitudes%22">Patients' attitudes</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Current therapy to slow disease progression in patients with neovascular age-related macular degeneration (AMD) often entails intra-vitreal injection of an anti-vascular endothelial growth factor (VEGF) agent, that begins with a three-month loading phase of four weekly injections followed by regular monthly visits with clinician-determined re-treatment. The effects of AMD on quality of life and visual function have been extensively reported in the literature, however, less is known about the burden imposed on patients by the arduous and often indefinite treatment schedule which habitually follows a diagnosis of wet AMD. To date, no systematic review has been conducted of research investigating patients’ experiences of anti-VEGF treatment for AMD. A systematic search of the Embase, Medline, PsycINFO and PubMed electronic databases was undertaken to identify all studies between January 2004 and December 2013, published in the English language and involving human participants. A hand-search of an additional four journals was conducted. Ten articles were identified for inclusion in this review. A critical appraisal was undertaken using the Critical Appraisal Skills Programme Qualitative Research Checklist and the results synthesised to form a narrative review. Few studies to date have investigated patients’ experiences of treatment for AMD. These studies have focused primarily on patients’ experiences of the injection procedure with respect to pain and anxiety. Anticipated discomfort is often greater than actual discomfort experienced during intra-vitreal injection. However, different stages of the treatment procedure produce varying levels of patient discomfort. No one method of anaesthesia has consistently been shown to be more effective in reducing discomfort associated with treatment. Common reasons underlying patient apprehension surrounding treatment include the thought of having an injection, fear of losing eyesight and fear of the unknown. Whilst these studies have not been without their methodological limitations, they provide a platform for further exploration of the patient experience. [ABSTRACT FROM PUBLISHER] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Psychology, Health & Medicine is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=100808470 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13548506.2014.936886 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 296 Subjects: – SubjectFull: Vascular endothelial growth factor antagonists Type: general – SubjectFull: Anesthesia Type: general – SubjectFull: Anxiety Type: general – SubjectFull: Fear Type: general – SubjectFull: Medical information storage & retrieval systems Type: general – SubjectFull: Psychology information storage & retrieval systems Type: general – SubjectFull: Injections Type: general – SubjectFull: MEDLINE Type: general – SubjectFull: Online information services Type: general – SubjectFull: Pain Type: general – SubjectFull: Patient satisfaction Type: general – SubjectFull: Research funding Type: general – SubjectFull: Retinal degeneration Type: general – SubjectFull: Systematic reviews Type: general – SubjectFull: Triamcinolone Type: general – SubjectFull: Visual analog scale Type: general – SubjectFull: Bevacizumab Type: general – SubjectFull: Patients' attitudes Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: Australia Type: general Titles: – TitleFull: Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boyle, Jessica – PersonEntity: Name: NameFull: Vukicevic, Meri – PersonEntity: Name: NameFull: Koklanis, Konstandina – PersonEntity: Name: NameFull: Itsiopoulos, Catherine IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2015 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 13548506 Numbering: – Type: volume Value: 20 – Type: issue Value: 3 Titles: – TitleFull: Psychology, Health & Medicine Type: main |
| ResultId | 1 |